Medicalsystem Biotechnology (300439.SZ) subsidiary has obtained multiple medical device registration certificates.
Meikang Biology (300439.SZ) announced that its holding subsidiary, Jiangxi Meikang Shengde Bio-Technology Co., Ltd. (...
Medicalsystem Biotechnology(300439.SZ) announced that its holding subsidiary, Jiangxi Meikangshengde Biotechnology Co., Ltd. (referred to as "Jiangxi Meikang"), has obtained the Medical Device Registration Certificate (In Vitro Diagnostic Reagent) issued by the Jiangxi Province Drug Administration. The products include: Tissue Type Plasminogen Activator-Inhibitor 1 Complex Test Kit (Chemiluminescent Immunoassay), Thrombin-Antithrombin Complex Test Kit (Chemiluminescent Immunoassay), Thrombin Regulation Protein Test Kit (Chemiluminescent Immunoassay), and Plasmin-2 Plasmin Inhibitor Complex Test Kit (Chemiluminescent Immunoassay).
Related Articles
Selected A-share Announcements | Over $1 Billion! Meixie Biology (688062.SH) Innovates in Cardiovascular Drugs Going Overseas
On September 17th, Hang Seng Bank (00011) spent HKD 23.8 million to repurchase 200,000 shares.
Beijing Hanyi Innovation Technology's controlling shareholder Xie Liqun and its concerted action persons intend to collectively reduce their shareholding by no more than 3%.
Selected A-share Announcements | Over $1 Billion! Meixie Biology (688062.SH) Innovates in Cardiovascular Drugs Going Overseas
On September 17th, Hang Seng Bank (00011) spent HKD 23.8 million to repurchase 200,000 shares.
Beijing Hanyi Innovation Technology's controlling shareholder Xie Liqun and its concerted action persons intend to collectively reduce their shareholding by no more than 3%.
